Alpha-2B adrenergic receptor agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain

Details for Australian Patent Application No. 2007337097 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.; Donello, John E.

Agent Davies Collison Cave

Pub. Number AU-A-2007337097

PCT Pub. Number WO2008/079728

Priority 60/871,715 22.12.06 US

Filing date 14 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079728 Priority application(s): WO2008/079728

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007337098-Functionalized amine-based corrosion inhibitors for galvanized metal surfaces and method of using same

2007337093-Improved diffuse light extended surface area water-supported photobioreactor